Oxford BioDynamics (LON:OBD) Stock Price Down 42.5% – Time to Sell?

Oxford BioDynamics Plc (LON:OBD) shares traded down 42.5% during trading on Monday . The company traded as low as GBX 2.10 ($0.03) and last traded at GBX 2.10 ($0.03). 3,478,932 shares traded hands during trading, an increase of 261% from the average session volume of 963,450 shares. The stock had previously closed at GBX 3.66 ($0.05).

Wall Street Analyst Weigh In

Separately, Shore Capital reissued a “house stock” rating on shares of Oxford BioDynamics in a report on Tuesday, June 18th.

Oxford BioDynamics Stock Up 2.6 %

The stock has a market capitalization of £3.68 million, a price-to-earnings ratio of -20.33 and a beta of 0.42. The firm has a 50 day simple moving average of GBX 4.98 and a 200-day simple moving average of GBX 6.88. The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.